These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 30417231)

  • 41. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction.
    Hochman JS; Sleeper LA; Webb JG; Dzavik V; Buller CE; Aylward P; Col J; White HD;
    JAMA; 2006 Jun; 295(21):2511-5. PubMed ID: 16757723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial.
    Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Kim HS; Park SJ
    JACC Cardiovasc Interv; 2011 Mar; 4(3):310-6. PubMed ID: 21435609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial.
    Hostettler K; Baty F; Kleiner R; Junker L; Tamm M; Brutsche M
    Swiss Med Wkly; 2018 Oct; 148():w14677. PubMed ID: 30378090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review of evidence for bosentan therapy for treatment of Eisenmenger syndrome.
    Hartwig BJ; Schultze B
    J Am Assoc Nurse Pract; 2019 Jan; 31(1):72-77. PubMed ID: 30475252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bosentan for high-risk outpatients with COVID-19 infection: a randomized, double blind, placebo-controlled trial.
    Shahbazi S; Vahdat Shariatpanahi Z; Shahbazi E
    EClinicalMedicine; 2023 Aug; 62():102117. PubMed ID: 37554128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent advances in the study of (-)clausenamide: chemistry, biological activities and mechanism of action.
    Chu SF; Zhang JT
    Acta Pharm Sin B; 2014 Dec; 4(6):417-23. PubMed ID: 26579412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abnormal macrophage response to microbial stimulus in a 43-year-old man with a severe form of atherosclerosis: a case report.
    Conti M; Sanna F; Farci GA; Uda S; Porcu G; Collu M; Bonatesta RR; Batetta B
    J Med Case Rep; 2010 Jun; 4():183. PubMed ID: 20565856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.
    Rosenstock J; Perkovic V; Johansen OE; Cooper ME; Kahn SE; Marx N; Alexander JH; Pencina M; Toto RD; Wanner C; Zinman B; Woerle HJ; Baanstra D; Pfarr E; Schnaidt S; Meinicke T; George JT; von Eynatten M; McGuire DK;
    JAMA; 2019 Jan; 321(1):69-79. PubMed ID: 30418475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial.
    Anand SS; Eikelboom JW; Dyal L; Bosch J; Neumann C; Widimsky P; Avezum AA; Probstfield J; Cook Bruns N; Fox KAA; Bhatt DL; Connolly SJ; Yusuf S;
    J Am Coll Cardiol; 2019 Jul; 73(25):3271-3280. PubMed ID: 31248548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endothelin and the Cardiovascular System: The Long Journey and Where We Are Going.
    Haryono A; Ramadhiani R; Ryanto GRT; Emoto N
    Biology (Basel); 2022 May; 11(5):. PubMed ID: 35625487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
    Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
    J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-Term Effects of Bosentan on Cardiovascular Events in Hispanic Patients with Intermittent Claudication: Four-Year Follow-up of the CLAU Trial : The CLAU Randomized Trial Long-Term Outcome.
    De Haro J; Bleda S; Gonzalez-Hidalgo C; Michel I; Acin F
    Am J Cardiovasc Drugs; 2019 Apr; 19(2):203-209. PubMed ID: 30417231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Bosentan on Claudication Distance and Endothelium-Dependent Vasodilation in Hispanic Patients With Peripheral Arterial Disease.
    De Haro J; Bleda S; Varela C; Esparza L; Acin F;
    Am J Cardiol; 2016 Jan; 117(2):295-301. PubMed ID: 26651453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50).
    Bonaca MP; Gutierrez JA; Creager MA; Scirica BM; Olin J; Murphy SA; Braunwald E; Morrow DA
    Circulation; 2016 Mar; 133(10):997-1005. PubMed ID: 26826179
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.